Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic Heart Disease.

Schwartz1

  • 1Department of Medicine, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Effective treatment for ischemic heart disease involves symptom relief and preventing major cardiac events. Current medical therapies, including lifestyle changes and medications, significantly improve patient outcomes and reduce the need for procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Boracic Acid in the Treatment of Leucorrhœa.

Buffalo medical and surgical journal·2023
Same author

Lupus erythematosus.

Archives of pediatrics·2010
Same author

Tyrosine Phosphorylation of Moesin in Arachidonic Acid-Stimulated Human Platelets.

Journal of thrombosis and thrombolysis·2001
Same author

Interobserver Reproducibility and Biological Variability of the Surgicutt II Bleeding Time.

Journal of thrombosis and thrombolysis·2001
Same author

Current management of perforated peptic ulcer.

Current surgery·2000
Same author

A new day.

Urologic oncology·2000
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Ischemic heart disease (IHD) management aims to alleviate symptoms, prevent acute coronary syndromes like unstable angina or myocardial infarction, and extend patient survival.
  • Therapeutic strategies have evolved significantly over four decades, with initial emphasis on revascularization procedures.

Purpose of the Study:

  • To highlight the impact of medical therapy in managing ischemic heart disease.
  • To emphasize the role of lifestyle modifications and pharmacologic agents in improving patient prognosis and reducing intervention rates.

Main Methods:

  • Review of established and emerging therapeutic strategies for ischemic heart disease.
  • Analysis of the impact of lifestyle changes (e.g., smoking cessation) and pharmacologic treatments (e.g., aspirin, beta-blockers, lipid-lowering agents) on clinical outcomes.

Related Experiment Videos

Main Results:

  • Coronary artery bypass surgery and percutaneous coronary interventions remain important but are complemented by effective medical management.
  • Appropriate medical therapy, including lifestyle changes and specific drug classes, demonstrably reduces acute ischemic events and prolongs life in patients with coronary artery disease.
  • Medical therapy can significantly decrease the necessity for revascularization procedures.

Conclusions:

  • Current medical therapies, encompassing lifestyle interventions and pharmacologic agents, are crucial for managing ischemic heart disease and improving long-term outcomes.
  • Ensuring all appropriate patients receive optimal medical therapy is paramount, even as research into new treatments for atherosclerosis progresses.